Immune repertoire-based signatures in pre-capillary pulmonary hypertension

S. Dumas (Le Plessis Robinson, France), M. Nakhleh (Le Plessis-Robinson, France), D. Montani (Le Kremlin-Bicêtre, France), B. Girerd (Le Kremlin-Bicêtre, France), A. Seferian (Le Kremlin-Bicêtre, France), P. Dorfmuller (Le Plessis-Robinson, France), I. Klingel-Schmitt (Le Plessis-Robinson, France), M. Vocelle (Le Plessis-Robinson, France), A. Courtier (Grenoble, France), O. Filipe-Santo (Grenoble, France), G. Parmentier (Grenoble, France), S. Perez (Grenoble, France), C. Superbielle (Paris, France), S. Caillat-Zucman (Paris, France), D. Philippe (Le Plessis-Robinson, France), G. Simonneau (Le Kremlin-Bicêtre, France), F. Perros (Le Plessis-Robinson, France), M. Humbert (Le Kremlin-Bicêtre, France), S. Cohen-Kaminsky (Le Plessis-Robinson, France)

Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Session: Pathobiology of pulmonary hypertension
Session type: Poster Discussion
Number: 3932
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Abstract

The presence of Ig deposits and tertiary lymphoid tissues (tLTs) connected to remodeled vessels in PAH lungs suggests lymphoid neogenesis as a critical step in maintaining immunity against local autoantigens. We searched for an immune signature in the lung and peripheral blood of PAH patients. T cell repertoire of 26 patients with iPAH, hPAH or PVOD (11 transplanted) and 24 controls were analyzed in peripheral purified CD4+ T cells and after laser-microdissection of perivascular tLTs. Genomic detection of T cell receptor (TCR) rearrangements by multiplex PCR on the TCR loci was used for exhaustive analysis of the combinatorial diversity of immune repertoires. Using advanced pattern recognition algorithms and statistics we identified 6 rearrangements that best discriminate patients and controls using peripheral blood samples, with an accuracy of 82%. One of these rearrangements was the most contributive to the signature (p<0.0035, Chi-square test), and 3 rearrangements were associated to the presence of circulating autoantibodies. Whereas repertoire diversity was preserved in the periphery, it was highly restricted and expanded in tLTs. This was also confirmed in a retrospective validation set of 10 cases from our tissue bank. Further analysis in the overall lung cases (n=21), revealed a set of 6 rearrangements that showed expansion in about 70% of lung cases, whatever the PH subtype, suggesting a local immune response with a public repertoire usage. Other highly expanded rearrangements in less cases or individual cases may represent a more private repertoire. These immune signatures provide additional clues for local autoimmunity in PAH, that could be further exploited for future biomarkers of PH condition



Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Dumas (Le Plessis Robinson, France), M. Nakhleh (Le Plessis-Robinson, France), D. Montani (Le Kremlin-Bicêtre, France), B. Girerd (Le Kremlin-Bicêtre, France), A. Seferian (Le Kremlin-Bicêtre, France), P. Dorfmuller (Le Plessis-Robinson, France), I. Klingel-Schmitt (Le Plessis-Robinson, France), M. Vocelle (Le Plessis-Robinson, France), A. Courtier (Grenoble, France), O. Filipe-Santo (Grenoble, France), G. Parmentier (Grenoble, France), S. Perez (Grenoble, France), C. Superbielle (Paris, France), S. Caillat-Zucman (Paris, France), D. Philippe (Le Plessis-Robinson, France), G. Simonneau (Le Kremlin-Bicêtre, France), F. Perros (Le Plessis-Robinson, France), M. Humbert (Le Kremlin-Bicêtre, France), S. Cohen-Kaminsky (Le Plessis-Robinson, France). Immune repertoire-based signatures in pre-capillary pulmonary hypertension. 3932

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms
Year: 2012

Pulmonary hypertension in sickle cell disease
Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease
Year: 2007

Endothelial NO and its pathophysiologic regulation
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007


Acute vasodilator response in different forms of pre-capillary pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Analysis of pulmonary endothelial microparticles, haemodynamics and functional class in pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Endothelial cells in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020
Year: 2021



Circulating fibrocytes and pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 210-212
Year: 2012


Circulating fibrocytes in pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011


Circulating fibrocytes and pulmonary arterial hypertension
Source: Eur Respir J 2011; 39: 210-212
Year: 2012


Molecular determinants of cardiac and pulmonary vascular remodeling in scleroderma-related pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases
Year: 2008


Roles of circulating and resident myeloid cell subpopulations in bronchopulmonary remodeling and pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Updates in pulmonary hypertension and other pulmonary vascular diseases
Source: Breathe, 15 (3) 241; 10.1183/20734735.0187-2019
Year: 2019



Predictors of a precapillary component in patients with postcapillary pulmonary hypertension
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020


Novel biomarkers in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015

Pulmonary arterial hypertension associated with sarcoidosis (BBS-PAH): mechanisms, hemodynamics and prognosis
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002

Multi-omic profiling in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020




Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015

The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008